The study emphasises on the role of the p53 tumor suppressor gene in the pathogenesis of ulcerative colitis - an inflammatory ...

Celltrion USA today announced a late-breaking post hoc analysis of the pivotal LIBERTY studies of ZYMFENTRA®, during the ...

The study emphasises on the role of the p53 tumor suppressor gene in the pathogenesis of ulcerative colitis - an inflammatory bowel disease.

Prademagene zamikeracel (pz-cel) could be a new treatment for rare genetic disease recessive dystrophic epidermolysis bullosa (RDEB).

Complementary and alternative therapies for Crohn’s disease, like acupuncture and meditation, are useful approaches to managing symptoms in combination with a treatment plan.

Former two-weight UFC champion, Georges St-Pierre has claimed if he would have accepted an offer to fight Octagon alum, Nate Diaz during their respective ...

Children who are exclusively breastfed for the first six months may subsequently have a lower risk of suffering from Crohn 's ...

The FDA approval of Selarsdi 130 mg/26 ml in a single-dose vial for intravenous infusion expands the label to include ...

After both receiving FDA approval in UC, J&J and Eli Lilly are racing for their IL-23 inhibitors to get the green light in ...

The 100 Best Thrillers Ever Made Diseases and medical issues have been used as dramatic devices since the dawn of drama ...

Eli Lilly and Johnson & Johnson are seeking label expansions for Omvoh and Tremfya, respectively, in Crohn’s disease ...

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced ...